These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35331419)

  • 1. Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia.
    Hovingh GK; Klausen IC; Heggen E; McCarty K; Zhou R; Isaac BF; Taub R; Langslet G; Kastelein JJP
    J Am Coll Cardiol; 2022 Mar; 79(12):1220-1222. PubMed ID: 35331419
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical criteria versus DNA diagnosis in heterozygous familial hypercholesterolemia: Is molecular diagnosis superior to clinical diagnosis?
    Schuster H; Luft FC
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):331-2. PubMed ID: 9514399
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.
    Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome.
    Rosenson RS; Najera SD; Hegele RA
    J Clin Lipidol; 2017; 11(1):294-296. PubMed ID: 28391899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Harrison SA; Bashir MR; Guy CD; Zhou R; Moylan CA; Frias JP; Alkhouri N; Bansal MB; Baum S; Neuschwander-Tetri BA; Taub R; Moussa SE
    Lancet; 2019 Nov; 394(10213):2012-2024. PubMed ID: 31727409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of children with heterozygous familial hypercholesterolemia.
    Reiner Ž; Sahebkar A
    Int J Cardiol; 2020 Apr; 304():177-178. PubMed ID: 31735366
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyromimetics as emerging therapeutic agents for nonalcoholic steatohepatitis: rationale for the development of resmetirom (MGL-3196).
    Alkhouri N
    Expert Opin Investig Drugs; 2020 Feb; 29(2):99-101. PubMed ID: 31868036
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple Ligation-dependent Probe Amplification Along with Whole Exome Sequencing Should be Required for the Diagnosis of Structural Heterozygous Familial Hypercholesteremia.
    Saotome M; Maekawa Y
    Intern Med; 2022; 61(19):2829-2830. PubMed ID: 36184533
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial hypercholesterolemia. There is a need for early detection and treatment.
    Bilheimer DW
    JAMA; 1987 Jan; 257(1):69-70. PubMed ID: 3783906
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterozygous Null
    Panach K; Garg A; Ahmad Z
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 28993407
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
    Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
    Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic detection of xanthomas in normal-sized Achilles' tendons of individuals with heterozygous familial hypercholesterolemia.
    Bude RO; Nesbitt SD; Adler RS; Rubenfire M
    AJR Am J Roentgenol; 1998 Mar; 170(3):621-5. PubMed ID: 9490941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.